1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Antisense Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 RNA Antisense Therapy 1.2.3 DNA Antisense Therapy 1.3 Market by Application 1.3.1 Global Antisense Therapy Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Cancer 1.3.3 Cardiovascular 1.3.4 HBV 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Antisense Therapy Market Perspective (2017-2028) 2.2 Antisense Therapy Growth Trends by Region 2.2.1 Antisense Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Antisense Therapy Historic Market Size by Region (2017-2022) 2.2.3 Antisense Therapy Forecasted Market Size by Region (2023-2028) 2.3 Antisense Therapy Market Dynamics 2.3.1 Antisense Therapy Industry Trends 2.3.2 Antisense Therapy Market Drivers 2.3.3 Antisense Therapy Market Challenges 2.3.4 Antisense Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Antisense Therapy Players by Revenue 3.1.1 Global Top Antisense Therapy Players by Revenue (2017-2022) 3.1.2 Global Antisense Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Antisense Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Antisense Therapy Revenue 3.4 Global Antisense Therapy Market Concentration Ratio 3.4.1 Global Antisense Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Antisense Therapy Revenue in 2021 3.5 Antisense Therapy Key Players Head office and Area Served 3.6 Key Players Antisense Therapy Product Solution and Service 3.7 Date of Enter into Antisense Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Antisense Therapy Breakdown Data by Type 4.1 Global Antisense Therapy Historic Market Size by Type (2017-2022) 4.2 Global Antisense Therapy Forecasted Market Size by Type (2023-2028) 5 Antisense Therapy Breakdown Data by Application 5.1 Global Antisense Therapy Historic Market Size by Application (2017-2022) 5.2 Global Antisense Therapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Antisense Therapy Market Size (2017-2028) 6.2 North America Antisense Therapy Market Size by Country (2017-2022) 6.3 North America Antisense Therapy Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Antisense Therapy Market Size (2017-2028) 7.2 Europe Antisense Therapy Market Size by Country (2017-2022) 7.3 Europe Antisense Therapy Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Antisense Therapy Market Size (2017-2028) 8.2 Asia-Pacific Antisense Therapy Market Size by Country (2017-2022) 8.3 Asia-Pacific Antisense Therapy Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Antisense Therapy Market Size (2017-2028) 9.2 Latin America Antisense Therapy Market Size by Country (2017-2022) 9.3 Latin America Antisense Therapy Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Antisense Therapy Market Size (2017-2028) 10.2 Middle East & Africa Antisense Therapy Market Size by Country (2017-2022) 10.3 Middle East & Africa Antisense Therapy Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Alnylam Pharmaceuticals 11.1.1 Alnylam Pharmaceuticals Company Detail 11.1.2 Alnylam Pharmaceuticals Business Overview 11.1.3 Alnylam Pharmaceuticals Antisense Therapy Introduction 11.1.4 Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022) 11.1.5 Alnylam Pharmaceuticals Recent Development 11.2 Ionis Pharmaceuticals, Inc. 11.2.1 Ionis Pharmaceuticals, Inc. Company Detail 11.2.2 Ionis Pharmaceuticals, Inc. Business Overview 11.2.3 Ionis Pharmaceuticals, Inc. Antisense Therapy Introduction 11.2.4 Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2017-2022) 11.2.5 Ionis Pharmaceuticals, Inc. Recent Development 11.3 Arbutus Biopharma (Tekmira) 11.3.1 Arbutus Biopharma (Tekmira) Company Detail 11.3.2 Arbutus Biopharma (Tekmira) Business Overview 11.3.3 Arbutus Biopharma (Tekmira) Antisense Therapy Introduction 11.3.4 Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2017-2022) 11.3.5 Arbutus Biopharma (Tekmira) Recent Development 11.4 Isarna Therapeutics 11.4.1 Isarna Therapeutics Company Detail 11.4.2 Isarna Therapeutics Business Overview 11.4.3 Isarna Therapeutics Antisense Therapy Introduction 11.4.4 Isarna Therapeutics Revenue in Antisense Therapy Business (2017-2022) 11.4.5 Isarna Therapeutics Recent Development 11.5 Arrowhead 11.5.1 Arrowhead Company Detail 11.5.2 Arrowhead Business Overview 11.5.3 Arrowhead Antisense Therapy Introduction 11.5.4 Arrowhead Revenue in Antisense Therapy Business (2017-2022) 11.5.5 Arrowhead Recent Development 11.6 Dicerna Pharmaceuticals 11.6.1 Dicerna Pharmaceuticals Company Detail 11.6.2 Dicerna Pharmaceuticals Business Overview 11.6.3 Dicerna Pharmaceuticals Antisense Therapy Introduction 11.6.4 Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022) 11.6.5 Dicerna Pharmaceuticals Recent Development 11.7 Quark Pharmaceuticals 11.7.1 Quark Pharmaceuticals Company Detail 11.7.2 Quark Pharmaceuticals Business Overview 11.7.3 Quark Pharmaceuticals Antisense Therapy Introduction 11.7.4 Quark Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022) 11.7.5 Quark Pharmaceuticals Recent Development 11.8 Benitec Biopharma 11.8.1 Benitec Biopharma Company Detail 11.8.2 Benitec Biopharma Business Overview 11.8.3 Benitec Biopharma Antisense Therapy Introduction 11.8.4 Benitec Biopharma Revenue in Antisense Therapy Business (2017-2022) 11.8.5 Benitec Biopharma Recent Development 11.9 Sylentis 11.9.1 Sylentis Company Detail 11.9.2 Sylentis Business Overview 11.9.3 Sylentis Antisense Therapy Introduction 11.9.4 Sylentis Revenue in Antisense Therapy Business (2017-2022) 11.9.5 Sylentis Recent Development 11.10 Gradalis 11.10.1 Gradalis Company Detail 11.10.2 Gradalis Business Overview 11.10.3 Gradalis Antisense Therapy Introduction 11.10.4 Gradalis Revenue in Antisense Therapy Business (2017-2022) 11.10.5 Gradalis Recent Development 11.11 Sarepta Therapeutics 11.11.1 Sarepta Therapeutics Company Detail 11.11.2 Sarepta Therapeutics Business Overview 11.11.3 Sarepta Therapeutics Antisense Therapy Introduction 11.11.4 Sarepta Therapeutics Revenue in Antisense Therapy Business (2017-2022) 11.11.5 Sarepta Therapeutics Recent Development 11.12 Biogen 11.12.1 Biogen Company Detail 11.12.2 Biogen Business Overview 11.12.3 Biogen Antisense Therapy Introduction 11.12.4 Biogen Revenue in Antisense Therapy Business (2017-2022) 11.12.5 Biogen Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Antisense Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of RNA Antisense Therapy Table 3. Key Players of DNA Antisense Therapy Table 4. Global Antisense Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Antisense Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Antisense Therapy Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Antisense Therapy Market Share by Region (2017-2022) Table 8. Global Antisense Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Antisense Therapy Market Share by Region (2023-2028) Table 10. Antisense Therapy Market Trends Table 11. Antisense Therapy Market Drivers Table 12. Antisense Therapy Market Challenges Table 13. Antisense Therapy Market Restraints Table 14. Global Antisense Therapy Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Antisense Therapy Market Share by Players (2017-2022) Table 16. Global Top Antisense Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Therapy as of 2021) Table 17. Ranking of Global Top Antisense Therapy Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Antisense Therapy Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Antisense Therapy Product Solution and Service Table 21. Date of Enter into Antisense Therapy Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Antisense Therapy Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Antisense Therapy Revenue Market Share by Type (2017-2022) Table 25. Global Antisense Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Antisense Therapy Revenue Market Share by Type (2023-2028) Table 27. Global Antisense Therapy Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Antisense Therapy Revenue Market Share by Application (2017-2022) Table 29. Global Antisense Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Antisense Therapy Revenue Market Share by Application (2023-2028) Table 31. North America Antisense Therapy Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Antisense Therapy Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Antisense Therapy Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Antisense Therapy Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Antisense Therapy Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Antisense Therapy Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Antisense Therapy Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Antisense Therapy Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Antisense Therapy Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Antisense Therapy Market Size by Country (2023-2028) & (US$ Million) Table 41. Alnylam Pharmaceuticals Company Detail Table 42. Alnylam Pharmaceuticals Business Overview Table 43. Alnylam Pharmaceuticals Antisense Therapy Product Table 44. Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022) & (US$ Million) Table 45. Alnylam Pharmaceuticals Recent Development Table 46. Ionis Pharmaceuticals, Inc. Company Detail Table 47. Ionis Pharmaceuticals, Inc. Business Overview Table 48. Ionis Pharmaceuticals, Inc. Antisense Therapy Product Table 49. Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2017-2022) & (US$ Million) Table 50. Ionis Pharmaceuticals, Inc. Recent Development Table 51. Arbutus Biopharma (Tekmira) Company Detail Table 52. Arbutus Biopharma (Tekmira) Business Overview Table 53. Arbutus Biopharma (Tekmira) Antisense Therapy Product Table 54. Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2017-2022) & (US$ Million) Table 55. Arbutus Biopharma (Tekmira) Recent Development Table 56. Isarna Therapeutics Company Detail Table 57. Isarna Therapeutics Business Overview Table 58. Isarna Therapeutics Antisense Therapy Product Table 59. Isarna Therapeutics Revenue in Antisense Therapy Business (2017-2022) & (US$ Million) Table 60. Isarna Therapeutics Recent Development Table 61. Arrowhead Company Detail Table 62. Arrowhead Business Overview Table 63. Arrowhead Antisense Therapy Product Table 64. Arrowhead Revenue in Antisense Therapy Business (2017-2022) & (US$ Million) Table 65. Arrowhead Recent Development Table 66. Dicerna Pharmaceuticals Company Detail Table 67. Dicerna Pharmaceuticals Business Overview Table 68. Dicerna Pharmaceuticals Antisense Therapy Product Table 69. Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022) & (US$ Million) Table 70. Dicerna Pharmaceuticals Recent Development Table 71. Quark Pharmaceuticals Company Detail Table 72. Quark Pharmaceuticals Business Overview Table 73. Quark Pharmaceuticals Antisense Therapy Product Table 74. Quark Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022) & (US$ Million) Table 75. Quark Pharmaceuticals Recent Development Table 76. Benitec Biopharma Company Detail Table 77. Benitec Biopharma Business Overview Table 78. Benitec Biopharma Antisense Therapy Product Table 79. Benitec Biopharma Revenue in Antisense Therapy Business (2017-2022) & (US$ Million) Table 80. Benitec Biopharma Recent Development Table 81. Sylentis Company Detail Table 82. Sylentis Business Overview Table 83. Sylentis Antisense Therapy Product Table 84. Sylentis Revenue in Antisense Therapy Business (2017-2022) & (US$ Million) Table 85. Sylentis Recent Development Table 86. Gradalis Company Detail Table 87. Gradalis Business Overview Table 88. Gradalis Antisense Therapy Product Table 89. Gradalis Revenue in Antisense Therapy Business (2017-2022) & (US$ Million) Table 90. Gradalis Recent Development Table 91. Sarepta Therapeutics Company Detail Table 92. Sarepta Therapeutics Business Overview Table 93. Sarepta Therapeutics Antisense TherapyProduct Table 94. Sarepta Therapeutics Revenue in Antisense Therapy Business (2017-2022) & (US$ Million) Table 95. Sarepta Therapeutics Recent Development Table 96. Biogen Company Detail Table 97. Biogen Business Overview Table 98. Biogen Antisense TherapyProduct Table 99. Biogen Revenue in Antisense Therapy Business (2017-2022) & (US$ Million) Table 100. Biogen Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Antisense Therapy Market Share by Type: 2021 VS 2028 Figure 2. RNA Antisense Therapy Features Figure 3. DNA Antisense Therapy Features Figure 4. Global Antisense Therapy Market Share by Application in 2021 & 2028 Figure 5. Cancer Case Studies Figure 6. Cardiovascular Case Studies Figure 7. HBV Case Studies Figure 8. Other Case Studies Figure 9. Antisense Therapy Report Years Considered Figure 10. Global Antisense Therapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Antisense Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Antisense Therapy Market Share by Region: 2021 VS 2028 Figure 13. Global Antisense Therapy Market Share by Players in 2021 Figure 14. Global Top Antisense Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Therapy as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Antisense Therapy Revenue in 2021 Figure 16. North America Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Antisense Therapy Market Share by Country (2017-2028) Figure 18. United States Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Antisense Therapy Market Share by Country (2017-2028) Figure 22. Germany Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Antisense Therapy Market Share by Region (2017-2028) Figure 30. China Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Antisense Therapy Market Share by Country (2017-2028) Figure 38. Mexico Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Antisense Therapy Market Share by Country (2017-2028) Figure 42. Turkey Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Antisense Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2017-2022) Figure 45. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Antisense Therapy Business (2017-2022) Figure 46. Arbutus Biopharma (Tekmira) Revenue Growth Rate in Antisense Therapy Business (2017-2022) Figure 47. Isarna Therapeutics Revenue Growth Rate in Antisense Therapy Business (2017-2022) Figure 48. Arrowhead Revenue Growth Rate in Antisense Therapy Business (2017-2022) Figure 49. Dicerna Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2017-2022) Figure 50. Quark Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2017-2022) Figure 51. Benitec Biopharma Revenue Growth Rate in Antisense Therapy Business (2017-2022) Figure 52. Sylentis Revenue Growth Rate in Antisense Therapy Business (2017-2022) Figure 53. Gradalis Revenue Growth Rate in Antisense Therapy Business (2017-2022) Figure 54. Sarepta Therapeutics Revenue Growth Rate in Antisense Therapy Business (2017-2022) Figure 55. Biogen Revenue Growth Rate in Antisense Therapy Business (2017-2022) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Alnylam Pharmaceuticals Ionis Pharmaceuticals, Inc. Arbutus Biopharma (Tekmira) Isarna Therapeutics Arrowhead Dicerna Pharmaceuticals Quark Pharmaceuticals Benitec Biopharma Sylentis Gradalis Sarepta Therapeutics Biogen